Literature DB >> 31247118

Severe Hyponatremia Is Often Drug Induced: 10-Year Results of a Prospective Pharmacovigilance Program.

Elena Ramírez1, Amelia Rodríguez1, Javier Queiruga1, Irene García1, Lucía Díaz1, Lucía Martínez1, Raúl Muñoz1, Mario Muñoz1, Hoi Y Tong1, José Carlos Martínez1, Alberto M Borobia1, Antonio J Carcas1, Jesús Frías1.   

Abstract

We conducted a prospective evaluation of drug-induced severe hyponatremia  (adverse drug reaction (ADR)) through the Prospective Pharmacovigilance Program from Laboratory Signals at Hospital over a period of 10 years. Cases of serum sodium (Na(s)) < 116 mM were recorded from July 2007 to June 2017 (first period). Also cases of Na(s) 116-122 mM were recorded from July 2012 to June 2017 (second period). Drugs were the primary cause of severe hyponatremia. The incidence rate of Na(s) < 116 mM by drugs was increased threefold over the decade. Compared with other causes of hyponatremia, patients with adverse drug reaction-serum sodium (ADR-Na(s)) in the first period were older (79 years (interquartile range (IQR) 68.6-89 vs. 65 years (IQR 48-81); P < 0.001) and were more often women (70.8% vs. 48.9% men, P < 0.001); in the second period were also older (79 years (IQR 65.3-89) vs. 63 years (IQR 46-80.6); P < 0.001) and were more often women (70% vs. 53%, P = 0.002), and ADR-Na(s) occurred more often in summer. The most frequent therapeutic groups of culprit drugs were the cardiovascular system and nervous system. The 65.3% in the first period and 71.2% in the second period of the ADR-Na(s) cases responded to hydration and had been diagnosed with hypovolemic hyponatremia.
© 2019 The Authors Clinical Pharmacology & Therapeutics © 2019 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31247118     DOI: 10.1002/cpt.1562

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  8 in total

1.  Hyponatremia Secondary to Decreased Oral Intake and SIADH and Possibly Exacerbated by Horsetail (Equisetum arvense).

Authors:  Duane Bates; Tam B Duong; Sasha Kheyson; Kim Moore
Journal:  Can J Hosp Pharm       Date:  2021

2.  Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report.

Authors:  Isabel J B van der Zalm; Tom J M Tobé; Susan J J Logtenberg
Journal:  J Med Case Rep       Date:  2020-06-29

3.  Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data.

Authors:  Elena Ramírez; Mikel Urroz; Amelia Rodríguez; Miguel González-Muñoz; Alberto Martín-Vega; Yuri Villán; Enrique Seco; Jaime Monserrat; Jesús Frías; Antonio J Carcas; Alberto M Borobia
Journal:  Front Pharmacol       Date:  2020-12-03       Impact factor: 5.810

Review 4.  Opioids and Falls Risk in Older Adults: A Narrative Review.

Authors:  Roosa-Emilia Virnes; Miia Tiihonen; Niina Karttunen; Eveline P van Poelgeest; Natalie van der Velde; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2022-03-15       Impact factor: 3.923

Review 5.  Do medicines commonly used by older adults impact their nutrient status?

Authors:  Rui Qi Chong; Ingrid Gelissen; Betty Chaar; Jonathan Penm; Janet My Cheung; Joanna E Harnett
Journal:  Explor Res Clin Soc Pharm       Date:  2021-09-03

6.  Utility of a Laboratory Alert System for Detecting Adverse Drug Reactions in Hospitalised Patients: Hyponatremia and Rhabdomyolysis.

Authors:  Mónica Valdés-Garicano; Gina Mejía-Abril; Diana Campodónico; Raúl Parra-Garcés; Francisco Abad-Santos
Journal:  Front Pharmacol       Date:  2022-07-06       Impact factor: 5.988

7.  The Incidence and Risk Factors of Hyponatremia in Pulmonary Tuberculosis.

Authors:  Tomohiko Yoshida; Hidenori Masuyama; Hiroki Yamagata; Makoto Miyabayashi; Shunichiro Onishi; Yosuke Inaba; Minoru Takemoto
Journal:  J Endocr Soc       Date:  2022-08-25

8.  Psychotropic drug-induced hyponatremia: results from a drug surveillance program-an update.

Authors:  Johanna Seifert; Martin Letmaier; Timo Greiner; Michael Schneider; Maximilian Deest; Christian K Eberlein; Stefan Bleich; Renate Grohmann; Sermin Toto
Journal:  J Neural Transm (Vienna)       Date:  2021-07-01       Impact factor: 3.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.